Arsenal Capital Partners made a majority investment in Pacific Urethanes LLC, a producer of specialty polyurethane foam materials based in Ontario, California. Financial terms of the transaction were not disclosed. Pacific Urethanes is the first investment in Arsenal’s strategy to build a specialty foam solutions and technologies platform.
NEW YORK, March 18, 2016 – Arsenal Capital Partners (Arsenal), a leading New York-based private equity firm that invests in middle-market specialty industrial and healthcare companies, announced today a majority investment in Pacific Urethanes LLC (Pacific Urethanes), a leading developer and producer of specialty polyurethane foam materials.
Headquartered in Ontario, California, Pacific Urethanes, develops and commercializes proprietary foam products that service its customers’ needs, with a focus on novel technologies for the bedding market. Pacific Urethanes’ technology and solutions are applicable to a broad range of markets including specialty bedding, furniture, packaging and recreational market segments.
“Pacific Urethanes has developed a unique market position by providing highly technical foams to a variety of end markets, keenly focused on addressing customers’ needs,” said Timothy Zappala, a Partner at Arsenal and Co-Head of the firm’s Specialty Industrials Group. “We have studied this market very well and believe that Pacific Urethanes has a differentiated model that we can further leverage as part of a broader platform.”
Darrell Nance, who will remain as President of Pacific Urethanes, said, “We look forward to the partnership with Arsenal. They have made a number of investments in the polyurethane sector over the years and have strong expertise in the foam market.” Neil Silverman, Vice President of Pacific Urethanes, added, “Their financial and industry capabilities will be important as we continue to support our customers’ growth plans, and expand our footprint.”
John Televantos, a Partner at Arsenal and Co-Head of the firm’s Specialty Industrials Group, said, “Pacific Urethanes is the first investment in our strategy to build a specialty foam solutions and technologies platform. We will make additional investments in Pacific Urethanes and add on more businesses in the near term.“
About Arsenal Capital Partners
Arsenal Capital Partners is a leading New York-based private equity firm that invests in middle market healthcare and specialty industrial companies. Arsenal makes investments in sectors where the firm has significant prior knowledge and experience. Arsenal targets businesses that have the potential for further value creation, and works closely with management to accelerate growth by leveraging the firm’s industry focus and operational improvement capabilities. Arsenal currently has $2.3 billion of committed equity capital. For additional information on Arsenal Capital Partners, please visit www.arsenalcapital.com.